Business
Chiron Corp., whose influenza vaccine shipments to the U.S. were blocked by British regulators, had ratings on $580 million in corporate debt cut Monday by Moody’s Investors Service.
Dec. 21, 2004
Ending a painful chapter in its corporate history, Chiron Corp. said Tuesday that the Securities and Exchange Commission had dropped an investigation related to the company’s failure to supply flu vaccine in 2004.
Feb. 8, 2006
The vaccine maker says Howard Pien’s base pay in 2005 will be $850,000, 54% more than his salary in 2003.
March 16, 2005
Authorities say animal rights activists may have placed the pipe bombs. A group condones the act but doesn’t claim responsibility for it.
Aug. 29, 2003
World & Nation
A previously unknown group, saying it was “for animal liberation through armed struggle,” took responsibility on Friday for two bombs that exploded the day before outside the offices of Emeryville, Calif.
Aug. 30, 2003
Robert Bennett is said to be focusing on probes into the company’s flu vaccine problem.
Oct. 19, 2004
The biotech firm acts amid criticism that its upfront fees stifle work on drugs for hepatitis C.
June 22, 2004
The goal is to help deal with contamination at the company’s flu shot factory in Liverpool.
Nov. 13, 2004
No group has claimed responsibility for blast at a company known for its ‘green’ products.
Sept. 27, 2003
Chiron Corp., which was the brains behind the first human vaccine produced through genetic engineering, has impressed scientists for several years.
May 17, 1988